Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Vaxart, Inc. | avir20171218_8k.htm |
Exhibit 99.1
Filed by Aviragen Therapeutics, Inc.
Pursuant to Rule 425 under the Securities Act of 1933, as amended
And deemed filed pursuant to Rule 14a-12
Of the Securities Exchange Act of 1934, as amended
Subject Company: Aviragen Therapeutics, Inc.
Commission File No.: 001-35285
